Gongbao Liu1, Baihui Liu1, Shan Zheng1, Kuiran Dong1, Rui Dong1. 1. Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai Key Laboratory of Birth Defects, Key Laboratory of Neonatal Disease, Ministry of Health 399 Wan Yuan Road, Shanghai 201102, China.
Abstract
BACKGROUND: Aberrant DNA methylation plays an important role in cancer and has been recognized to contribute to the activity of oncogenes and inactivity of tumor suppressor genes. RAS association domain family (RASSF) members have been shown to be epigenetically silenced by promoter methylation in cancers, including hepatoblastoma. METHODS: We assessed the methylation patterns in the gene of RASSF5 from hepatoblastoma tissue samples harvested from patients using high-throughput mass spectrometry on a matrix-assisted laser desorption/ionization time-of-flight mass array. RESULTS: Hypermethylation was found in the RASSF5 gene transcribed regionand was correlated with downregulation of RASSF5 RNA expression levels in the hepatoblastoma samples. CONCLUSIONS: The results indicate that aberrant methylation of RASSF5 may contribute to its downregulated mRNA expression in hepatoblastoma. IJCEP
BACKGROUND: Aberrant DNA methylation plays an important role in cancer and has been recognized to contribute to the activity of oncogenes and inactivity of tumor suppressor genes. RAS association domain family (RASSF) members have been shown to be epigenetically silenced by promoter methylation in cancers, including hepatoblastoma. METHODS: We assessed the methylation patterns in the gene of RASSF5 from hepatoblastoma tissue samples harvested from patients using high-throughput mass spectrometry on a matrix-assisted laser desorption/ionization time-of-flight mass array. RESULTS: Hypermethylation was found in the RASSF5 gene transcribed regionand was correlated with downregulation of RASSF5 RNA expression levels in the hepatoblastoma samples. CONCLUSIONS: The results indicate that aberrant methylation of RASSF5 may contribute to its downregulated mRNA expression in hepatoblastoma. IJCEP
Authors: Lirong Pei; Jeong-Hyeon Choi; Jimei Liu; Eun-Joon Lee; Brian McCarthy; James M Wilson; Ethan Speir; Farrukh Awan; Hongseok Tae; Gerald Arthur; Jennifer L Schnabel; Kristen H Taylor; Xinguo Wang; Dong Xu; Han-Fei Ding; David H Munn; Charles Caldwell; Huidong Shi Journal: Epigenetics Date: 2012-06-01 Impact factor: 4.528
Authors: Mark R Morris; Luke B Hesson; Kate J Wagner; Neil V Morgan; Dewi Astuti; Robert D Lees; Wendy N Cooper; JouAnn Lee; Dean Gentle; Fiona Macdonald; Takeshi Kishida; Richard Grundy; Masahiro Yao; Farida Latif; Eamonn R Maher Journal: Oncogene Date: 2003-10-02 Impact factor: 9.867
Authors: Colleen C McLaughlin; Mark S Baptiste; Maria J Schymura; Philip C Nasca; Michael S Zdeb Journal: Am J Epidemiol Date: 2006-03-01 Impact factor: 4.897